The size of the Cell Culture Market in North America is estimated to worth USD 5.8 billion in 2020 and USD 9.35 Billion by 2024, growing at a CAGR of 10.02% during the forecast period.
Cells are the fundamental building blocks of human life. Tissue culture was developed first in the 20th century for studying the behaviour of cells in response to stress and other external factors, be it induced or natural. Gradually techniques developed that enabled the study of single cells and cell culture was born.
Cell culture involves the dispersal cells into an artificial environment composed of nutrient solutions, a suitable surface for the growth of cells, and favourable conditions of temperature, humidity and gaseous atmosphere. This enables the researcher to precisely measure the responses of the cell in use the data in prospective drugs, and analysis of carcinogenic agents and viruses. Cell cultures can be established from various sources such as blood or even small fragments of tissues, called biopsies. Other sources include lymphocytes and fibroblasts each with its own positives.
The major factors affecting the North America Cell Culture market include the increasing incidence of chronic diseases, the increasing regulatory approvals for cell-culture based vaccines and a rise in demand for mAbs. This along with the technological advancements in cell culture products and the growing adoption of single-use technologies is expected to drive the market forward in the coming years.
In spite of the numerous drivers for the market, factors such as ethical concerns regarding the treatment of animals as test subjects and the high costs associated with research in the field continue to hamper the growth of the market.
The North America region has the highest market share globally in spite of having a below-average growth rate. The growth rate is the second-lowest of all the regions and can be due to the fact that most markets in the region are already in their prime state of development.
This research report has been segmented and sub-segmented into the following categories:
North America has the highest share in the market. The United States and Canada, both together constitute the North American market.
The factors that affect the North America cell culture market growth are increasing occurrence rate of chronic diseases, rise in demand for mAbs and also rise in regulatory approvals for cell culture-based vaccines. The largest share is accounted by North America which is due to the high demand in biopharmaceutical products, firmly-established healthcare systems, great adoption of advance technology, and the rising commonness of chronic diseases, growth in pharmaceutical research and development and also the entry of new key players in North America.
In the cell culture of North America, the developed infrastructure and the existence of international funding organizations in this region also been instrumented in increasing the demand for the cell culture market and these drive the market growth.
Companies playing a leading role in the North America Cell Culture Market profiled in this report are Thermo Fisher Scientific, GE Healthcare, Merck KGaA, Sartorius AG, Eppendorf AG, Lonza AG, Corning, Becton, Dickinson and Company, Promocell GmbH and Hi-Media Laboratories.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemiology
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 Product
5.1.1 Introduction
5.1.2 Equipment
5.1.3 Consumables
5.1.5 Y-o-Y Growth Analysis, By Product
5.1.6 Market Attractiveness Analysis, By Product
5.1.7 Market Share Analysis, By Product
5.2 Application
5.2.1 Introduction
5.2.2 Biopharmaceutical
5.2.2.1 Vaccine Production
5.2.2.2 Diagnostics
5.2.2.3 Recombinant Therapeutic Proteins
5.2.3 Cancer Research
5.2.4 Stem Cell Technologies
5.2.5 Drug Screening and Development
5.2.6 Tissue Engineering & Regenerative Medicine
5.2.7 Other Applications
5.2.8 Y-o-Y Growth Analysis, By Application
5.2.9 Market Attractiveness Analysis, By Application
5.2.10 Market Share Analysis, By Application
5.3 End User
5.3.1 Introduction
5.3.2 Pharmaceutical and Biotechnology Companies
5.3.3 Research Institutes
5.3.4 Y-o-Y Growth Analysis, By End User
5.3.5 Market Attractiveness Analysis, By End User
5.3.6 Market Share Analysis, By End User
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Product
6.1.3.3 By Application
6.1.3.4 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Product
6.1.4.3 By Application
6.1.4.4 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Product
6.1.5.3 By Application
6.1.5.4 By End User
6.2 United States
6.3 Canada
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five Analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Thermo Fisher Scientific
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 GE Healthcare
8.3 MerckKgA
8.4 Sartorius AG
8.5 Eppendorf AG
8.6 Lonza AG
8.7 Corning
8.8 Becton, Dickinson and Company
8.9 Promocell GmbH
8.10 Hi-Media Laboratories
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
Appendix
Related Reports
Feb 2020
Download Sample
